Vir Biotechnology (VIR) EBITDA Margin Growth (3y) (2021 - 2026)
Vir Biotechnology (VIR) EBITDA Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vir Biotechnology | 1.38 Bn | 1.38 Bn | - | -45.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.59 Mn |
| Dec 31, 2025 | 22,980.00 |
| Sep 30, 2025 | -7.23 Mn |
| Jun 30, 2025 | -919,995.00 |
| Mar 31, 2025 | -468,473.00 |
| Dec 31, 2024 | -101,709.00 |
| Sep 30, 2024 | -966,713.00 |
| Jun 30, 2024 | -519,495.00 |
| Mar 31, 2024 | 787,309.00 |
| Dec 31, 2023 | 542,356.00 |
| Sep 30, 2023 | -253,152.00 |
| Jun 30, 2023 | -560,017.00 |
| Mar 31, 2023 | 102,988.00 |
| Dec 31, 2022 | 620,142.00 |
| Sep 30, 2022 | 345,048.00 |
| Jun 30, 2022 | 119,305.00 |
| Mar 31, 2022 | 92,274.00 |
| Dec 31, 2021 | 92,755.00 |
| Sep 30, 2021 | 113,898.00 |